Assessment of bone remodeling in patients with type 2 diabetes mellitus

Authors

  • Sain Sattar Safarova Azerbaijan Medical University, Baku, Azerbaijan Republic,

DOI:

https://doi.org/10.14739/2310-1210.2019.1.155812

Keywords:

diabetes mellitus, bone tissue

Abstract

Despite higher femoral neck and lumbar spine bone mineral density (BMD), individuals with type 2 diabetes mellitus (DM2) have 1,5-2 times increased fracture risk than in a healthy population. These data suggest that some indicators may be more informative regarding the prediction of low-trauma fractures risk, which observed in patients with diabetes mellitus, and BMD measurement does not reflect in essence the real trend towards the development of bone remodeling disorders in these patients.

Aim: to identify complex interdependencies between the bone mineral and organic components and the risk of low-trauma fractures associated with metabolic changes in DM2.

Materials and methods. A cross-sectional study was conducted in patients diagnosed with DM2 (n = 137); the control group consisted of 82 individuals. Calciotropic hormones, serum levels of bone remodeling markers and X-ray densitometry were studied in all the patients.

Results. Patients with DM2 had lower P1NP and b-CTx values, reflecting a slower metabolism of bone tissue compared to the control group. The results of densitometry revealed no significant differences in BMD between the patients with DM2 and control.

Conclusions. High rate of bone remodeling was found at the elevated values of parathyroid hormone with a predominance of bone resorption, which is confirmed by a positive correlation between parathyroid hormone level and the serum biochemical marker of bone resorption. There is a relationship between DM2 duration and a decrease in BMD, which is the most pronounced in men aged up to 50 years.

 

References

Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2009) Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int., 84(1), 45–55. doi: 10.1007/s00223-008-9195-5.

Becerra-Tomás, N., Estruch, R., Bulló, M., Casas, R., Díaz-López, A., Basora, J., et al. (2014) Increased Serum Calcium Levels and Risk of Type 2 Diabetes in Individuals at High Cardiovascular Risk. Diabetes Care., 37(11), 3084–3091. doi: 10.2337/dc14-0898.

Lederer, E. (2014) Regulation of serum phosphat. J Physiol., 592(18), 3985–3995. doi: 10.1113/jphysiol.2014.273979.

Yamamoto, M., & Sugimoto, T. (2016) Advanced Glycation End Products, Diabetes, and Bone Strength. Curr Osteoporos Rep., 14(6), 320–326. doi: 10.1007/s11914-016-0332-1.

Liamis, G., Liberopoulos, E., Barkas, F., & Elisaf, M. (2014) Diabetes mellitus and electrolyte disorders. World J Clin Cases., 2(10), 488–496. doi: 10.12998/wjcc.v2.i10.488.

Fisher, A., Srikusalanukul, W., Fisher, L., & Smith, P. N. (2017) Lower serum P1NP/β-CTX ratio and hypoalbuminemia are independently associated with osteoporotic nonvertebral fractures in older adults. ClinInterv Aging. 12, 1131–1140. doi: 10.2147/CIA.S141097.

Nakashima, A., Yokoyama, K., Yokoo, T., & Urashima, M. (2016) Role of vitamin D in diabetes mellitus and chronic kidney disease. World J Diabetes., 7(5), 89–100. doi: 10.4239/wjd.v7.i5.89.

Moisa, S. S. (2014) Calcitonin and Parathyrin are Glucoregulating Hormones. J Mol Genet Med, S1, 024. doi: 10.4172/1747-0862.S1-024.

Hinton, P. S. (2016) Role of reduced insulin-stimulated bone blood flow in the pathogenesis of metabolic insulin resistance and diabetic bone fragility. Medical hypotheses, 93, 81–86. doi: 10.1016/j.mehy.2016.05.008.

Jørgensen, H. S., Winther, S., Bøttcher, M., Hauge, E., Rejnmark, L., Svensson, M., & Ivarsen, P. (2017) Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol., 18, 284. doi: 10.1186/s12882-017-0692-5

Downloads

How to Cite

1.
Safarova SS. Assessment of bone remodeling in patients with type 2 diabetes mellitus. Zaporozhye Medical Journal [Internet]. 2019Feb.8 [cited 2024Nov.22];(1). Available from: http://zmj.zsmu.edu.ua/article/view/155812

Issue

No. 1 (2019)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)